International journal of antimicrobial agents
-
Int. J. Antimicrob. Agents · Aug 2017
Multicenter Study Comparative StudyMacrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time point.
Therapy directed against atypical pathogens in patients with community-acquired pneumonia (CAP) is often recommended. This post-hoc analysis evaluated the effect of addition of a macrolide to ceftaroline fosamil or ceftriaxone treatment in atypical CAP. ⋯ These results suggest that empirical antibiotic therapy against atypical pathogens may improve early clinical response rate. This hypothesis is best evaluated in a prospective trial.